Desensitization to biological agents used in rheumatology

Biological agents such as monoclonal antibodies and fusion proteins are widely used for the treatment of patients with various rheumatic disorders, influencing the quality of life, disability and even mortality in patients. However, biological agents can evoke adverse reactions of different grades o...

Descripción completa

Detalles Bibliográficos
Autores principales: Makowska, Joanna, Lewandowska-Polak, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174799/
https://www.ncbi.nlm.nih.gov/pubmed/32322121
http://dx.doi.org/10.5114/reum.2020.93510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174799/
https://www.ncbi.nlm.nih.gov/pubmed/32322121
http://dx.doi.org/10.5114/reum.2020.93510

Ejemplares similares